The application of high flow nasal cannula in the painless bronchoscopy of high risk obstructive sleep apnea-hypopnea sysdrome

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044105

Enrollment

Unknown

Registered

2021-03-11

Start date

2021-03-15

Completion date

Unknown

Last updated

2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea-hypopnea sysdrome

Interventions

experimental group:high flow nasal cannula

control group :ordinary oxygen mask inhalation

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing painless bronchoscopy; 2. Aged > 18 years; 3. The ASA class I- III; 4. STOP-BANG score >= 3.

Exclusion criteria

Exclusion criteria: 1. Coagulation dysfunction or nasal bleeding tendency; 2. Severe cardiac disease, including severe aortic stenosis, severe mitral stenosis, hemodynamic disturbance caused by severe arrhythmia, acute myocardial infarction within the last 6 months, cardiac surgery within the last 6 months, etc. 3. Significant hypoxemia (SpO2 < 90%); 4. Upper respiratory tract infection or lung infection; 5. Patients refused to participate in this study.

Design outcomes

Primary

Measure	Time frame
oxygen saturation;	—

Secondary

Measure	Time frame
blood pressure;heart rate;	—

Countries

China

Contacts

Public ContactWen Zhang

Zhejiang Cancer Hospital

wendymos@126.com+86 15990145873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026